The Third UN High Level Meeting (HLM) on NCDs took place on September 27, 2018, in New York. Although IDF welcomed several aspects of the Political Declaration, it also regretted some notable omissions. This report, developed in the last quarter of 2018, provides an in-depth response to the Political Declration.
In 2017, The International Diabetes Federation (IDF) and its partners spoke with authority and delivered action across a wide range of initiatives covering diabetes care and prevention, epidemiology, statistics, health economics, health education and health system reform.
On the occasion of the BRICS Leaders’ Summit, which took place between 3-5 September 2017 in China, IDF worked with its Members and BCV members in Brazil, South Africa and Russia to develop policy recommendations to improve access to diabetes care in their countries. The recommendations can be downloaded by clicking on the links below.
In December 2016, IDF held a consultation with the Blue Circle Voices (BCV) network with the objective of establishing the priorities of the network. The main issue identified by the BCV members was access and affordability of medicines, devices and medical care, followed by education, prevention and finally discrimination. This document presents the four priorities identified, together with an IDF call to action to governments to improve them.
A publication of the IDF Europe Region, Integrating diabetes evidence into practice: challenges and opportunities to bridge the gaps, identifies the local and European-wide challenges of implementing diabetes evidence into practice and makes recommendations based on the findings. Diabetes presents a significant health and economic burden across Europe, affecting 58 million people and costing 145 billion euros per annum. There is an urgent need to identify ways in which implementation of evidence can be improved.
This toolkit intends to inform all IDF Members of the IDF call to action on the road to the 2018 UN HLM on NCDs, and to provide them with tools to successfully engage with national policymakers to demand stronger action in the years to come, activate the national press to promote the IDF call to action and support the IDF online campaign on the road to the 2018 HLM.
In June 2017, IDF held the second consultation with the Blue Circle Voices network. This consultation was focused on Barriers to Access to Diabetes Care, Medicines and Supplies. Some 70 participants from across the world responded to the survey. The main barrier to care identified by the network is affordability of medicines and care.
The IDF Annual Report 2016 provides an overview of the main activities and projects of the Federation in 2016. Highlights included World Diabetes Day, the launch of the IDF School of Diabetes and the start of the IDF Blue Circle Voices, a new global network representing people living with or affected by diabetes.
In December 2016, IDF held a consultation with the Blue Circle Voices network with the objective of establishing the priorities of the network. Some 82 participants from 43 different countries responded to the survey. The main issue identified by the BCV members was access and affordability of medicines, devices and medical care, followed by education, prevention and finally discrimination.
The Global Diabetes Scorecard contains the views of 125 IDF Member Associations from 104 countries on how far their national governments have progressed in responding to the diabetes challenge by December 2013 and sets the baseline for future monitoring.
The first ever Charter setting out the fundamental rights of the 415 million people currently living with diabetes. The document places the rights of people with diabetes, their parents and carers into three focus areas; the rights to care; information and education and social justice, whilst at the same time acknowledging the responsibilities held by people with diabetes.
The IDF Annual Report 2015 provides an overview of the main activities and projects of the Federation in 2015. Highlights included the publication of the IDF Diabetes Atlas Seventh Edition, the World Diabetes Congress in Vancouver, Canada, and the inclusion of non-communicable diseases (including diabetes) in the Sustainable Development Goals (SDGs.
Since 2000, The International Diabetes Federation has been working to improve the outlook for people with type 1 diabetes in developing countries through its Life for a Child (LFAC) Programme. LFAC currently supports children’s diabetes centres in 46 developing countries and provides insulin, other essential supplies and the best possible care to over 18,000 of the poorest children with diabetes.
Global trends in demography, migration, urbanisation, consumption and production are creating new challenges that threaten to damage human health and livelihoods, and derail human development and economic growth. Two urgent challenges in the 21st century are the global diabetes epidemic and climate change. Both are rapidly accelerating, are fuelled by changes in the way we live and work, and will have intergenerational effects on health, wellbeing and security.
The Diabetes and Climate Change Report - published in 2012 - aims to outline the interconnections between climate change and diabetes; establish the co-benefits of combating two global risks in an integrated policy agenda; and inform the global discussion on health and sustainable development.
The Global Diabetes Plan was launched in 2011, a milestone year when world leaders met at UN headquarters in New York to agree actions on diabetes and other non-communicable diseases. The document calls on the United Nations and its agencies, governments, civil society, the private sector and the global diabetes community to turn the tide of diabetes.
A Guide to National Diabetes Programmes (NDPs) builds on the 2003 NDP Toolbox and sets out considerations and source material for developing and implementing NDPs. Topics include measuring the problem (disease prevalence, morbidity and cost), intervening to mitigate the problem (prevention, early diagnosis, services and care of people with diabetes) and evaluating the impact of the interventions.